diclofenac and endothelin-1

diclofenac has been researched along with endothelin-1 in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (45.45)18.2507
2000's6 (54.55)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Masuda, K; Oshika, T; Shoji, N2
Heller, A; Koch, T; Neuhof, H; Patt, B; Schmeck, J; van Ackern, K1
Ahlborg, G; Lundberg, JM1
Janzen, R; Koch, T; Münter, K; Neuhof, H; Schmeck, J1
Gröschler, A; Heller, A; Koch, T; Neuhof, H; Recker, A; Schmeck, J; Urbaschek, R1
Gluth, H; Koch, T; Konrad, C; Krafft, P; Schmeck, J; Schöffel, S; Wendel-Wellner, M1
Hu, CL; Liu, LY; Ma, LJ; Mei, YA; Zhang, ZH1
Cristofoletti, R; Fabricio, AS; Navarra, P; Souza, GE; Veiga, FH1
Chono, K; Funatsu, T; Hirata, T; Keto, Y; Kimoto, A; Sasamata, M1
Favre, J; Henry, JP; Lallemand, F; Marie, I; Richard, V; Solans, V; Thuillez, C1

Trials

1 trial(s) available for diclofenac and endothelin-1

ArticleYear
Cyclooxygenase inhibition potentiates the renal vascular response to endothelin-1 in humans.
    Journal of applied physiology (Bethesda, Md. : 1985), 1998, Volume: 85, Issue:5

    Topics: Adult; Blood Glucose; Blood Pressure; Cardiac Output; Cyclooxygenase Inhibitors; Diclofenac; Endothelin-1; Glucagon; Heart Rate; Humans; Insulin; Lung; Male; Oxygen Consumption; Renal Circulation; Splanchnic Circulation; Vascular Resistance

1998

Other Studies

10 other study(ies) available for diclofenac and endothelin-1

ArticleYear
[Anterior chamber inflammation after the injection of endothelin-1 into the vitreous and the effect of an anti-prostaglandin agent].
    Nippon Ganka Gakkai zasshi, 1997, Volume: 101, Issue:3

    Topics: Animals; Anterior Chamber; Cyclooxygenase Inhibitors; Diclofenac; Endothelin-1; Female; Inflammation; Male; Prostaglandin Antagonists; Proteins; Rabbits; Vitreous Body

1997
Inflammatory reaction via arachidonic acid cascade after intravitreal injection of endothelin-1.
    Current eye research, 1998, Volume: 17, Issue:2

    Topics: Administration, Topical; Animals; Anterior Chamber; Aqueous Humor; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Endothelin-1; Eye Proteins; Female; Inflammation; Injections; Leukotriene B4; Male; Rabbits; Radioimmunoassay; Uveitis, Anterior; Vitreous Body

1998
The role of endothelin-1 as a mediator of the pressure response after air embolism in blood perfused lungs.
    Intensive care medicine, 1998, Volume: 24, Issue:6

    Topics: Analysis of Variance; Animals; Cyclooxygenase Inhibitors; Diclofenac; Disease Models, Animal; Embolism, Air; Endothelin Receptor Antagonists; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Hypertension, Pulmonary; In Vitro Techniques; Oligopeptides; Perfusion; Phenylpropionates; Piperidines; Pulmonary Artery; Pulmonary Embolism; Pyrimidines; Rabbits; Radioimmunoassay; Thromboxane A2; Time Factors; Vascular Resistance

1998
Endothelin-1 and thromboxane A2 increase pulmonary vascular resistance in granulocyte-mediated lung injury.
    Critical care medicine, 1998, Volume: 26, Issue:11

    Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Animals; Cyclooxygenase Inhibitors; Diclofenac; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Female; Granulocytes; In Vitro Techniques; Male; N-Formylmethionine Leucyl-Phenylalanine; Perfusion; Phenylpropionates; Prospective Studies; Pulmonary Artery; Pyrimidines; Rabbits; Random Allocation; Respiratory Distress Syndrome; Thromboxane A2; Thromboxane B2; Vascular Resistance

1998
Impact of endothelin-1 in endotoxin-induced pulmonary vascular reactions.
    Critical care medicine, 2000, Volume: 28, Issue:8

    Topics: Animals; Cyclooxygenase Inhibitors; Diclofenac; Endothelin Receptor Antagonists; Endothelin-1; Female; Lipopolysaccharides; Male; Phenylpropionates; Prospective Studies; Pulmonary Artery; Pulmonary Wedge Pressure; Pyrimidines; Rabbits; Thromboxane A2

2000
Interaction of acetylcholine and endothelin-1 in the modulation of pulmonary arterial pressure.
    Critical care medicine, 2000, Volume: 28, Issue:12

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Cyclooxygenase Inhibitors; Diclofenac; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Endothelin Receptor Antagonists; Endothelin-1; Female; Hypertension, Pulmonary; In Vitro Techniques; Male; Peptides, Cyclic; Pulmonary Circulation; Pulmonary Wedge Pressure; Rabbits; Thromboxane A2; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Vasodilation

2000
ET-1 inhibits B-16 murine melanoma cell migration by decreasing K(+) currents.
    Cell motility and the cytoskeleton, 2004, Volume: 58, Issue:2

    Topics: Animals; Cell Movement; Diclofenac; Endothelin-1; Melanoma, Experimental; Mice; Potassium; Potassium Channels

2004
The effects of selective and nonselective cyclooxygenase inhibitors on endothelin-1-induced fever in rats.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2005, Volume: 288, Issue:3

    Topics: Animals; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Endothelin-1; Fever; Indomethacin; Injections, Intraperitoneal; Injections, Intraventricular; Intubation, Gastrointestinal; Lipopolysaccharides; Male; Organic Chemicals; Pyrazoles; Rats; Rats, Wistar; Sulfonamides

2005
Mucosal acid causes gastric mucosal microcirculatory disturbance in nonsteroidal anti-inflammatory drug-treated rats.
    European journal of pharmacology, 2007, Jan-05, Volume: 554, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Diclofenac; Dinoprostone; Endothelin-1; Gastric Acid; Gastric Mucosa; Male; Microcirculation; Pyrazoles; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sulfonamides

2007
Role of endogenous endothelin in endothelial dysfunction in murine model of systemic sclerosis: tight skin mice 1.
    Fundamental & clinical pharmacology, 2008, Volume: 22, Issue:6

    Topics: Acetylcholine; Animals; Bosentan; Cyclooxygenase Inhibitors; Diclofenac; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Prostaglandins; Receptors, Endothelin; Scleroderma, Systemic; Sulfonamides; Vasodilation; Vasodilator Agents

2008